SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing heightened investor attention as the market rotates into quantum computing stocks, buoyed by significant industry partnerships with NVIDIA and active government contracts for space and defense applications. The community is actively discussing the stock's potential for a valuation re-rating, highlighting its neutral-atom technology and institutional interest as key drivers for long-term growth versus shorter-term momentum peers.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors rally around the company's confirmed control of 92.5% of the Tanbreez rare earth project following final regulatory approval from Greenland. The community is focused on the stock's potential as a strategic play for Western supply chain independence and is actively debating whether current momentum will lead to a sustained breakout or a near-term consolidation.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending following a post-earnings sell-off where investors reacted negatively to weak forward guidance and the departure of co-founder Reed Hastings from the board, despite the company posting strong quarterly revenue and profit figures. While many retail participants are framing the price drop as a "no-brainer" buying opportunity and actively loading up on dips, others are debating whether the stock is undergoing a structural narrative shift or simply experiencing a temporary liquidity reset after a strong pre-earnings run.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and significant debate as investors react to the company's aggressive Bitcoin acquisition strategy and its correlation with crypto market movements. Community sentiment is deeply divided between bulls betting on a massive short squeeze driven by institutional accumulation, and skeptics who are raising concerns over the sustainability of its debt-funded business model.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is currently trending as investors focus on the potential of its CAN-2409 immunotherapy platform and upcoming data presentations for prostate and lung cancer. The community is actively discussing the company's regulatory progress, recent insider accumulation, and the potential for a significant valuation re-rating ahead of expected BLA filings.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strive Inc. (ASST) is trending as investors react to aggressive institutional accumulation and the companys ongoing strategy of utilizing digital credit to increase its Bitcoin treasury holdings. Community sentiment remains polarized, with bulls focused on the potential for long-term growth as a Bitcoin proxy, while critics remain vocal about the stock's history of dilution and the impact of previous reverse splits.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is experiencing high volatility driven by reports of an anticipated executive order from the White House supporting research into ibogaine for PTSD treatment. While some community members are betting on a massive short squeeze due to the stock's low float and high speculative interest, others are warning of dilution risks and past patterns of aggressive selling, leading to intense debate among traders regarding the sustainability of the current price action.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is experiencing significant volatility and downward pressure as market sentiment reacts to competitive threats from new AI-powered design tools, despite some community members remaining bullish on its long-term enterprise dominance and integration capabilities. Investors are actively debating whether current price levels represent a generational buying opportunity or a structural decline as the company navigates an increasingly crowded software ecosystem.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is sparking intense debate as community members weigh the potential of the newly launched LitVM testnet against ongoing price stagnation and concerns over lagging performance compared to broader crypto markets. While some investors remain bullish on its foundational reliability, institutional accumulation, and future utility, others dismiss recent updates as ineffective, leading to a polarized discussion around long-term viability and the asset's ability to decouple from recent downward trends.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is currently capturing significant attention as investors speculate on a broader nuclear sector rally, fueled by a positive mandate from the White House regarding space-based nuclear energy and an ongoing institutional board reorganization. The community remains deeply divided, balancing excitement over potential long-term commercial milestones like Aurora reactor criticality against skepticism regarding the company's lack of current revenue and the heavy volume of insider share sales.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The partnership makes Medirom the operator for World ID verification across Japan.</li><li>Its rollout will use Medirom’s 300 locations, along with flagship and pop-up sites, to scale quickly.</li><li>Investors reacted positively to the prospect of a new, recurring revenue stream beyond wellness.</li></ul>Shares of Medirom Healthcare Technologies Inc. (MRM) jumped about 10% in after-hours trading on Friday after the company announced a partnership tied to OpenAI CEO Sam Altman’s World project, positioning Medirom as a key operator in Japan’s rollout of “Proof of Human” verification technology.<h2 class="st-heading-2">Medirom Picked To Operate World ID Locations In Japan</h2>Medirom said it has entered into a master service agreement with Tools for Humanity and the World Foundation to operate World’s “Proof of Human” verification locations across Japan. World is a biometric identity project co-created by Sam Altman and Alex Blania that aims to help users prove they are human online without revealing personal identity.Under the agreement, Medirom will be responsible for running verification sites using World’s technology, including the deployment of Orb devices that confirm humanness through privacy-preserving biometric methods.<h2 class="st-heading-2">Nationwide Rollout&nbsp;</h2>Medirom plans to use its nationwide footprint of roughly 300 locations to accelerate deployment. The company said it will also establish flagship verification sites and temporary pop-up locations in commercial and public spaces, supported by a newly formed internal task force dedicated to the project.The company expects the initiative to generate revenue over time through operating fees and related services as adoption scales.<h2 class="st-heading-2">‘Proof of Human’ Gains Focus Amid AI Boom</h2><a href="https://stocktwits.com/news-articles/markets/cryptocurrency/sam-altman-world-eye-scanning-startup-uk/chlEkYsRby1">World project was created</a> to address growing concerns that advances in AI are making it harder to distinguish humans from bots online. The project uses blockchain-based infrastructure to provide users with an anonymous World ID that can be used across participating platforms.Tools for Humanity, which led the initial development of the World project, said Japan’s high level of technology adoption makes it a key market for expanding digital identity infrastructure.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for Medirom was ‘extremely bullish’ amid ‘high’ message volume.<figure class="image"><img style="aspect-ratio:974/141;" src="https://news.stocktwits-cdn.com/mrm_ss_png_f13ca655da.webp" alt="mrm ss.png" width="974" height="141"><figcaption>MRM sentiment and message volume as of December 26| Source: Stocktwits</figcaption></figure>One user said they can see the stock “rallying” next week.<stembedurl>https://stocktwits.com/squarellim/message/640209408</stembedurl><a href="https://stocktwits.com/symbol/MRM">Medirom’s stock</a> has more than doubled so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the MEDIROM Healthcare Technologies logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Medirom Stock Jumps 10% After Hours On Deal To Run Sam Altman’s World ‘Proof Of Human’ Sites In Japan

The deal positions Medirom at the center of Japan’s push to deploy human-verification infrastructure as AI adoption accelerates.

Equity

MEDIROM Healthcare Technologies (NYSE:MRM) Trading 2.8% Higher - Here's Why

MEDIROM Healthcare Technologies (NYSE:MRM) Trading 2.8% Higher - Here's Why...

MEDIROM Healthcare Technologies (NYSE:MRM) Stock Price Up 1% - Should You Buy?

MEDIROM Healthcare Technologies (NYSE:MRM) Trading 1% Higher - Here's Why...

MEDIROM Healthcare Technologies (NYSE:MRM) Trading 1.6% Higher - What's Next?

MEDIROM Healthcare Technologies (NYSE:MRM) Trading Up 1.6% - Should You Buy...

Shares of Medirom Healthcare Technologies surged over 250% in premarket trading on Friday after the Tokyo-based wellness and healthtech company announced a partnership with World, the “proof of human” protocol co-founded by OpenAI’s Sam Altman and Alex Blania of Tools for Humanity.Medirom said it will install World ID’s Orb authentication devices across 100 of its Re.Ra.Ku relaxation studios in Japan this month, expanding to 200 locations nationwide. The rollout represents the largest Orb deployment in Japan so far, aimed at providing broad access to a system that verifies individuals’ “humanness” without revealing their identity.The Orb, an advanced imaging device, issues a World ID once verification is complete, which is stored in the World App for use across compatible services. Medirom said its integration of the devices underscores its push to fuse healthcare with technology while accelerating World ID adoption in Japan.The company operates over 300 wellness salons under various brands, including Re.Ra.Ku, Spa Re.Ra.Ku, and Bell Epoc, and also develops digital health solutions, including the Lav training app and the Mother Bracelet, a battery-free smart tracker used in industries from caregiving to construction.On Stocktwits, retail sentiment for Medirom was ‘extremely bullish’ amid ‘extremely high’ message volume.Some retail traders speculated on sharp price targets for Medirom, with one suggesting the stock could open at around $7, while another said it might climb to $10 during the session.<stembedurl>https://stocktwits.com/madstocks123/message/630074517</stembedurl><stembedurl>https://stocktwits.com/HellenicRenegade/message/630087145</stembedurl><a href="https://stocktwits.com/symbol/MRM">Medirom’s stock</a> has risen nearly 41% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Is Medirom Healthcare Technologies Stock Surging Over 250% Premarket Today?

The surge followed news that Medirom will deploy Sam Altman’s World ID Orb devices across its Re.Ra.Ku studios in Japan.

Medirom Healthcare Technologies ($MRM) ADR shares were down 12% on Monday, even as the Japan-based wellness salon operator announced a series A equity raise by its subsidiary.Medirom subsidiary Medirom Mother Labs Inc. has raised an aggregate total of 260.3 million yen, or about $1.7 million, at a pre-money equity valuation of JPY9 billion, or about $58.6 million in its Series A equity financing, the company said in a statement.The firm noted NFES Technologies Inc. was the lead investor in the financing round, along with several other public companies in Japan, including M3 Inc. and Elematec Corp. Certain individual investors also participated in the round. Medirom Mother Labs has closed financings with six investors to date and hopes to complete this round by December 31.“We are very excited that our Medirom Mother Labs subsidiary has received such significant validation from strategic partners as our lead investor NFES Technologies Inc.,” Kouji Eguchi, Medirom’s CEO, said in a statement. “The pre-money valuation of 9 billion yen is approximately multiples of Medirom’s current NASDAQ listing market capitalization…further validates our technology, business model, and growth potential.” Retail chatter on Stocktwits indicated a mixed take on the stock.<stembedurl>https://stocktwits.com/HumbleTrader187/message/596459081</stembedurl><stembedurl>https://stocktwits.com/biff1/message/596382806</stembedurl><stembedurl>https://stocktwits.com/Z_interceptor/message/596439765</stembedurl>Medirom operates over 300 wellness salons across Japan under its Re.Ra.Ku brand.Shares of the firm are down 80% year-to-date.(Calculations based on an exchange rate of JPY153.64 to $1)For updates and corrections, email newsroom[at]stocktwits[dot]com.

Medirom Healthcare Stock Dips On Series A Equity Raise: Retail’s Divided

 NFES Technologies Inc. is the lead investor in the latest financing round.

MEDIROM Healthcare Technologies, Inc. owns, develops, operates, manages, and supports relaxation salons through the franchising and direct ownership of such salons. It provides relaxation and bodywork services. The firm operates two synergistic lines of businesses: Relaxation Salon Segment (retail) and Digital Preventative Healthcare Segment (healthtech). The company was founded by Kouji Eguchi on July 13, 2000 and is headquartered in Tokyo, Japan.

MRM
MEDIROM Healthcare Technologies Inc - ADR

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest MRM News

MRMMEDIROM Healthcare Technologies Inc - ADR